Core Viewpoint - The trend of Chinese innovative drugs going global continues to gain momentum in 2026, with local pharmaceutical companies like Rongchang Biologics achieving significant overseas licensing agreements, marking a shift from simple product output and price competition to a new phase of value competition based on systematic R&D and original innovation [1][2][3] Group 1: Collaboration Models - Multiple local pharmaceutical companies, including Rongchang Biologics, have recently signed significant overseas licensing agreements, indicating a diversification in collaboration models [2] - Rongchang Biologics signed an exclusive licensing agreement with AbbVie for its PD-1/VEGF bispecific antibody drug RC148, receiving an upfront payment of $650 million and potential milestone payments up to $4.95 billion, along with double-digit royalties on net sales outside Greater China [2] - The collaboration aims to accelerate the global development and commercialization of RC148, enhancing Rongchang Biologics' brand value and international influence [2] Group 2: Market Trends and Characteristics - The overseas licensing of Chinese innovative drugs has shown significant characteristics, including a shift towards diverse collaboration models and a focus on the clinical value of drugs rather than just price advantages [3] - Oncology drugs are the primary focus for overseas licensing, with a few endocrine and autoimmune drugs also achieving international collaborations [3] - The total value of overseas licensing transactions for Chinese innovative drugs exceeded $130 billion in 2025, with over 150 transactions, marking a historical high [4] Group 3: Policy and Support - The National Medical Insurance Administration is actively supporting the "going global" strategy for Chinese pharmaceuticals, aiming to enhance the internationalization of the Chinese pharmaceutical industry [5] - The Ministry of Industry and Information Technology is planning to develop a pharmaceutical industry cooperation platform, facilitating the transition of Chinese pharmaceutical companies from exporting raw materials to innovative drugs and high-end medical devices [6] Group 4: Future Outlook - The overall trend of Chinese innovative drugs going global is expected to remain strong in 2026, driven by improved core capabilities and the global demand for innovation [7] - The oncology sector will continue to be the main battlefield, while metabolic and cardiovascular drug fields are anticipated to see increased international transactions [7] - The industry is shifting from a general explosion to a layered prosperity, with only assets that demonstrate global differentiation and clinical certainty likely to secure high-quality orders [7]

性能决定主流选择 成本困局待破 与卓越性能相伴的，是砷化镓电池居高不下的成本。马斯克"星链"项目采用转换效率仅20%左右的晶硅 电池片，核心原因就是成本控制。"三结砷化镓太阳能电池片的转换效率普遍超30%，但成本却是晶硅 电池的数倍。"蔡坤煌表示。 ● 本报记者杨洁 商业航天大幕持续拉开，航天器的"能量心脏"——太空能源系统成为产业链竞争的关键赛道，其中砷化 镓(GaAs)太阳能电池凭借卓越性能目前占据市场主流。砷化镓太阳能电池技术在光电转换效率、极端环 境适应性上远超传统硅基电池，但也由于材料稀缺、制造工艺复杂而成本高昂。近日，中国证券报记者 走进三安光电（600703）砷化镓太阳能电池片产线一线，探寻太空能源核心技术的现状与未来。 "砷化镓是第二代半导体的代表，最显著的优势就是电子迁移率高。"三安光电砷化镓事业部总经理、天 津三安总经理蔡坤煌向记者解释，砷化镓系列材料的禁带宽度能与太阳光谱高度匹配，且作为直接带隙 材料，光子能量可直接激发电子跃迁，能量损耗远低于传统硅基电池。更关键的是，其在高低温交替变 更、强辐射的太空极端环境中能稳定运行，效率衰减慢、使用寿命长，成为航天器能源系统的首选。 作为国内较早 ...

上述发言人介绍，意见重点是对城际铁路规划建设进行规范和引导。 具体包括，在标准条件方面，坚持适度超前、不能过度超前的原则，以需求为导向，提出新建城际铁路 近期双向客流密度不低于1500万人次/年，审慎建设与既有干线铁路平行的城际铁路项目，既有城际铁 路运营5年后客流密度未达到预期指标50%的地区要暂停新建城际铁路项目。明确新建城际铁路原则上 在地上敷设，设计速度一般为每小时120-200公里，集约高效、因地制宜确定技术标准，从严控制工程 造价。 国家发展改革委城市和小城镇改革发展中心研究员潘昭宇表示，城际铁路要与干线铁路、市域(郊)铁 路、城市轨道交通无缝化衔接、一体化服务、融合式发展。意见提出，有序实现城际铁路与干线铁路、 城市轨道交通、市域(郊)铁路票制互通、支付兼容、安检互认、信息共享、应急联动，将有效推进多层 次轨道交通"四网融合"，提高城际铁路运输服务质量。 在监管要求方面，要求国家铁路局履行行业监督管理部门职责，压实地方政府工程质量安全监管责任， 加强城际铁路建设运营监管体制机制建设。落实地方政府支出责任，明确新建城际铁路项目资本金比例 不低于50%，不得违规举债融资，既有城际铁路运营10年后未实 ...

"太空算力是继通信、导航、遥感之后的新一代天基信息服务能力，是融合航天、能源、计算与人工智 能的交叉领域。"航天科技（000901）集团五院原副院长李明在星算.智联2026年太空算力研讨会上表 示。他指出，太空算力已成为全球科技竞争与商业航天发展（000547）的新赛道，更是数字经济高质量 发展的新引擎。 随着AI技术的不断发展，行业对算力的需求持续飙升。将计算能力部署于太空，已逐渐从幻想变成产 业加速落地的现实考量。但算力"上天"，并非仅是将算力基础设施进行迁移，而需要从理念到模式的系 统性更新。 ● 本报记者王婧涵 从"地算"迈向"天算" 行业普遍认为，太空算力的核心价值，在于突破地面算力在能源供给、全球覆盖能力等方面的限制，充 分利用好卫星在太空中采集到的资源。 中国信通院总工程师何宝宏表示，通过在轨部署算力节点，行业有望实现从传统"天感地算"向"天数天 算"乃至"地数天算"模式的转变。这不仅能提升遥感、通信、导航等空间信息服务的时效性与自主性， 也更有助于破解超大规模算力集群面临的能源供给问题。 中国信通院云计算与大数据研究所总工程师郭亮表示，为应对全球低轨资源争夺、构建未来空天信息基 础设施，应通过 ...

2026年开年以来，中国创新药出海热潮持续升温，荣昌生物等本土药企接连达成重磅海外授权合作，延 续了2025年的高光表现。与此同时，国家医保局、国家药监局等多部门协同发力，为药械"走出去"筑牢 政策与平台支撑。业内人士认为，中国创新药出海已告别单一的"单品输出"与"价格竞争"模式，正式迈 入以体系化研发能力、源头创新能力为核心的价值竞争新阶段。中外药企合作也从简单技术转让，升级 为全球协同开发、风险共担、利益绑定的深度共创模式。中国创新药正以平等的技术输出方身份，深度 参与全球医药产业竞争，实现从量的积累到质的飞跃。 ● 本报记者 傅苏颖 启明创投合伙人、医疗创新行业共同负责人陈侃日前在接受中国证券报记者采访时认为，近几年中国创 新药海外授权呈现出显著特点，核心是合作模式多元化发展，且全程以创新药自身价值为导向。其一， 合作模式打破单一局限，企业可结合自身产品管线布局及发展需求，灵活选择适配的合作路径。其二， 授权逻辑实现根本性转变，从过去依靠价格优势吸引合作，转向聚焦药物临床价值。其三，授权的靶点 与领域更趋聚焦，尽管热门靶点竞争激烈，但能够成功出海的产品均具备鲜明差异化优势。 止于至善投资总经理何理对中国 ...

Core Viewpoint - Tian Gong International has made significant strides in the research and engineering validation of key metal materials for nuclear fusion by joining the "Fusion High-End Metal Materials Research Laboratory" [1] Group 1: Company Development - Tian Gong International evolved from a struggling small factory with a loan of 2000 yuan to a leading global enterprise in tool steel [1] - The company has transitioned from producing basic items to advanced materials such as high-speed tool steel and titanium alloys, showcasing its innovation in powder metallurgy technology [1] - The chairman emphasizes the inseparable relationship between high-end manufacturing and high-end materials, aiming to accelerate the development of cutting-edge materials like high-nitrogen steel and fusion steel [1][3] Group 2: Technological Advancements - The company has developed the "smallest" steel, with particle sizes finer than human hair, utilizing high-alloy powder metallurgy technology [2] - Traditional methods yield mold steel with a lifespan of approximately 6000 cycles, while powder metallurgy can extend this to 20,000 cycles, indicating a significant improvement in durability [2] - The company is actively developing new materials such as high-boron steel for extreme conditions in fusion reactors, focusing on engineering applications [3] Group 3: Future Directions - The company is committed to continuous innovation in high-performance materials to meet market demands, with a focus on high-nitrogen steel for robotics and other applications requiring exceptional wear resistance [4] - The chairman highlights the importance of self-sufficiency in core materials for the company's growth, aligning with the "14th Five-Year Plan" which emphasizes the development of emerging industries [5] - Future strategies include mergers and acquisitions to enhance capabilities in key material sectors, particularly titanium alloys, while also fostering potential business segments for capital market entry [5]

Group 1 - A total of 37 companies in the non-ferrous metal industry have released performance forecasts for 2025, with 23 companies expecting positive results, resulting in a positive forecast ratio of approximately 62.16% [1] - The performance of upstream companies in the non-ferrous metal sector has significantly improved due to rising metal prices, while some midstream and downstream companies have shown notable performance differentiation [1] - Companies like China Rare Earth have forecasted a net profit of approximately 143 million to 185 million yuan for 2025, indicating a turnaround from losses, driven by market conditions and strategic adjustments [2] Group 2 - Companies such as Xianglu Tungsten Industry expect a net profit of 125 million to 180 million yuan for 2025, reflecting a growth of 239.66% to 301.11% due to improved market conditions and pricing power [2] - The surge in metal prices has led to significant stock price increases for related companies, with silver futures and spot prices reaching historical highs, prompting risk warnings from companies like Silver Industry [3] - The rising prices of upstream metal raw materials have adversely affected the performance of downstream companies, with companies like Laimu Co. reporting increased production costs due to high copper prices [4] Group 3 - Companies are actively developing new customers and increasing the proportion of high-value-added products to enhance profit levels, with Zhongyi Technology forecasting a net profit of 60 million to 80 million yuan for 2025, representing a year-on-year increase of 171.26% to 195.02% [5] - The overall market environment has posed challenges for some companies, such as Jin Baize, which expects a net profit decline of 59.04% to 39.84% due to rising raw material costs and industry pressures [4]

为感谢客户长期陪伴，活动特别设置了"沃德20年客户颁奖"环节，多位客户代表分享了与交通银行共同 成长的财富故事，展现了沃德财富的品牌信赖与价值。 1月23日，交通银行"沃野万理·金玉良缘—沃德财富万里行"贵金属配置投资报告会在济南成功举办。本 次活动是交通银行"沃德财富万里行"全国活动的重要组成部分，同时也是沃德财富品牌创立20周年的开 篇活动，旨在进一步满足客户优化资产配置与财富保值增值需求。 活动在富有传统文化韵味的氛围中拉开序幕。现场设有漆扇绘制、古法香道等非遗体验环节，嘉宾们还 亲笔书写新春福字，感受文化传承与财富管理的交融。交通银行山东省分行表示，将始终坚持"以客户 为中心"的服务理念，通过专业化的财富管理服务，助力客户优化资产结构、守护财富安全、实现资产 保值增值。 本次济南站活动是交通银行财富管理专业能力与文化服务融合的一次集中展示。未来，交通银行山东省 分行将继续依托沃德财富品牌，为客户提供更专业、更有温度的金融服务，携手客户稳步迈向财富未 来。 -CIS- 在"2026年黄金投资论坛"环节，行业专家围绕黄金历史、价格走势及资产配置策略展开深入解读，结合 全球经济与地缘政治形势，为在场嘉宾分析 ...

Core Viewpoint - The A-share space photovoltaic sector continues to experience high enthusiasm, driven by Elon Musk's statements regarding space solar energy and production capacity goals, alongside multiple listed companies disclosing their progress in this area [1] Group 1: Market Dynamics - Musk announced a plan for SpaceX and Tesla to jointly create 200GW of photovoltaic capacity in the U.S. over the next three years, with each company responsible for 100GW, primarily for ground data centers and space AI satellites [1] - The industry faces challenges such as high electricity costs and lengthy commercialization cycles, but the expectation of a trillion-dollar market continues to fuel the sector's growth [1] Group 2: Technological Developments - The space photovoltaic technology route is undergoing rapid iteration and breakthroughs, with competition focusing on cost control and conversion efficiency [2] - Gallium arsenide batteries have dominated the market due to their radiation resistance and stability, but their high costs limit scalability, leading to a focus on silicon and perovskite technologies for cost advantages [2] - Heterojunction (HJT) technology is gaining traction due to its short production process and adaptability to high labor cost scenarios, making it a key direction for overseas capacity expansion [2] Group 3: Company Initiatives - Mingyang Smart Energy announced plans to acquire control of Zhongshan Dehua, which has significant expertise in gallium arsenide space solar cells, marking Mingyang's entry into the space photovoltaic sector [3] - JunDa Co. is initiating a strategic transformation by investing in Shanghai Xingyi Chip Energy, although it is still in the R&D verification stage [3] - Trina Solar has established long-term layouts in crystalline silicon, perovskite tandem cells, and III-V gallium arsenide multi-junction cells, and is collaborating with domestic and international aerospace institutions [3] Group 4: Industry Outlook - The space photovoltaic technology route is expected to evolve in three stages, with gallium arsenide batteries leading high-value aerospace scenarios in the short term, HJT technology penetrating low Earth orbit satellite missions in the next five years, and perovskite tandem cells supporting GW-level space data center deployments in the long term [4] - The Chinese low Earth orbit satellite photovoltaic market is projected to exceed $3 billion by 2030, with global market potential reaching $500 billion to $1 trillion if the 100GW space data center deployment phase is achieved [4] Group 5: Challenges Ahead - The industry is still in its introduction phase, facing multiple challenges for commercialization, including high current space photovoltaic electricity costs of $2-3 per kilowatt-hour, which is significantly higher than ground photovoltaic costs [5][6] - The extreme conditions in space require photovoltaic materials to have high radiation resistance and temperature tolerance, which presents additional challenges for technology maturity and cost stability [6] - The commercial aerospace industry's growth provides ample application scenarios for space photovoltaics, and companies with core technologies and stable supply capabilities are expected to benefit from industry development [6]

尽管晶硅电池在太空环境中存在耐温性差、衰减快、寿命短等短板，但马斯克通过可重复火箭技术提高 卫星发射频次，尝试弥补这一缺陷。 蔡坤煌表示，航天业界正从全产业链角度系统性考量成本优化。柔性电池技术成为重要突破方向——该 技术可大幅减少航天器太阳翼的体积与重量，进而降低发射端成本。 "砷化镓是第二代半导体的代表，最显著的优势就是电子迁移率高。"三安光电砷化镓事业部总经理、天 津三安总经理蔡坤煌向记者解释，砷化镓系列材料的禁带宽度能与太阳光谱高度匹配，且作为直接带隙 材料，光子能量可直接激发电子跃迁，能量损耗远低于传统硅基电池。更关键的是，其在高低温交替变 更、强辐射的太空极端环境中能稳定运行，效率衰减慢、使用寿命长，成为航天器能源系统的首选。 作为国内较早布局砷化镓多结太阳能电池片研发与生产的企业，三安光电的技术迭代轨迹印证了行业发 展方向。2014年，公司正式推出三结锗基刚性砷化镓太阳能电池外延片，转换效率达30%；2015年实现 批量供货；2017年转换效率提升至31.5%。"2023年、2025年我们又相继研发出四结、五结刚性电池 片，转换效率进一步突破至34.5%。"蔡坤煌坦言，尽管多结技术能持续提升效率 ...